All In Biotech

Company

Shanghai Henlius Biotech

Drugs filed under this Drugs@FDA sponsor name, and trials whose lead sponsor matches it. The same company may file under other names.

Last checked: Nov 20, 2026Source: Drugs@FDA, ClinicalTrials.gov

NDAs and BLAs

2

2 still marketed

Novel approvals

0

Approvals since 2021

3

Originals and new uses

Phase 3 trials

30

Registered, any status

Trials by phase

All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.

Recent approvals

Originals and efficacy supplements, newest first.

Drugs in development (16)

Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.

Open in pipeline
  • SerplulimabHLX10, HLX43Phase 325 trials

    Shanghai Henlius Biotech · Non Small Cell Lung Cancer, Carcinoma, Hepatocellular, SCLC, Extensive Stage

  • HLX07Phase 34 trials

    Shanghai Henlius Biotech · Colon Cancer Adenocarcinoma, Squamous NSCLC, Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

  • HLX22Phase 34 trials

    Shanghai Henlius Biotech · HER2 + Breast Cancer, HER2-low Hormone Receptor Positive Breast Cancer, Gastroesophageal-junction Cancer

  • EU-sourced KeytrudaPhase 32 trials

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer

  • HLX87Phase 32 trials

    Shanghai Henlius Biotech · HER2 + Breast Cancer

  • US-sourced KeytrudaPhase 32 trials

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer, Non Squamous Non Small Cell Lung Cancer

  • HLX04-OPhase 31 trial

    Shanghai Henlius Biotech · Age Related Macular Degeneration

  • HLX11Phase 31 trial

    Shanghai Henlius Biotech · Breast Cancer, Breast Neoplasms, HER2-positive Breast Cancer

  • HLX13Phase 31 trial

    Shanghai Henlius Biotech · Hepatocellular Carcinoma (HCC)

  • HLX15Phase 31 trial

    Shanghai Henlius Biotech · Newly Diagnosed Multiple Myeloma

  • HLX17Phase 31 trial

    Shanghai Henlius Biotech · Non-Squamous Non-Small Cell Lung Cancer

  • HX22Phase 31 trial

    Shanghai Henlius Biotech · HER2 + Breast Cancer

  • HLX01Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

  • HLX26Phase 21 trial

    Shanghai Henlius Biotech · NSCLC Stage IV

  • HLX53Phase 21 trial

    Shanghai Henlius Biotech · Carcinoma, Hepatocellular

  • HLX79Phase 21 trial

    Shanghai Henlius Biotech · Membranous Nephropathy, Lupus Nephritis (LN)

Recruiting Phase 3 trials

Largest first.

Marketed drugs (2)

Newest FDA action first.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.